Cannabis Legalization

Congress passes ‘Cannabidiol and Marijuana Research Expansion Act’

Tens of #millions of #medical #patients who could benefit from new, #FDA-approved prescription #CBD got the tiniest of breaks from #Congress. The #US #House of #Representatives voted this evening to pass the #Cannabidiol and #Marihuana Research Expansion Act, which is intended to allow new drug research and #development. The #Senate voted unanimously to pass the bill in #March.

#Doctors have reported for decades that marijuana’s federal Schedule I status—designating it as a drug as dangerous as heroin—blocks basic drug #trials. A generation of patients has undertaken those trials on themselves. (Ninety-two percent of medical cannabis users reported efficacy in one state survey in 2014.) Currently, 38 states have legalized cannabis medically or for all adults, yet ‘marijuana’ remains a Schedule I substance.

The new Act—sponsored by Sen. Dianne #Feinstein (D-CA), Sen. #Chuck #Grassley (R-IA), and eight other senators—doesn’t change weed’s Schedule I status. But it does force the federal government to allow more #researchers to #grow medical #cannabis, and allows doctors to talk about pot without fear of losing their medical license, as well as other modest tweaks. About 91% of #Americans support medical #marijuana legalization, Pew Research finds. About 68% of Americans support full legalization. But Sen. Feinstein—a long-serving #Democrat representing the largest legal cannabis market on the planet, which did $5.1 billion in legal sales last year—is focused on further research, not legalizing it federally.

Distributed by: Cannabis Broadcast Station/ Infinity Broadcast Network
http://www.cannabisbroadcaststation.com

@cannabisbroadcaststaion
#cannabisnews #news

Sponsored by MDXclusive: www.mdxclusive.com

banner

Products You May Like

Leave a Reply

Your email address will not be published. Required fields are marked *